Medicinal liquor formula capable of strengthening immunity of population with acquired immunodeficiency syndrome

Abstract

The invention discloses a medicinal liquor formula capable of strengthening the immunity of population with an acquired immunodeficiency syndrome. The medicinal liquor formula contains the following preparing raw materials by percentages: 1.34% of cornu cervi pantotrichum, 1.34% of deer blood, 0.27 of penis et testis cervi, 2.70% of deer's sinew, 5.34% of deer skin collagen, 2.70% of deer-horn glue, 2.70% of tortoise-plastron glue, 13.35% of a deer bone, 1.34% of deer brain, 10.68% of deer bone marrow, 26.70% of venison, 1.20% of radix rehmanniae preparata, 1.60% of American ginseng, 0.80% of astragalus membranaceus, 0.80% of angelica sinensis, 0.80% of dried radix rehmanniae, 0.80% of achyranthes bidentata, 0.80% of asparagus cochinchinensis, 1.60% of wolfberries and 0.80% of a dwarf lilyturf root. The medicinal liquor is capable of continuously transforming a bone extract into kidney qi through the effects of tonifying the kidneys to produce sperm and regulating qi and blood, dispersing the kidney qi to a whole body through triple energizers, promoting qi and blood to circulate in meridians, nourishing various tissues and organs of the body and supplementing human nutrition, so that the human body reaches an ideal balance state, thereby improving the organism immunity of specific population.

Description

technical field [0001] The invention relates to the technical field of production and application of traditional Chinese medicines, in particular to a medicinal wine formula for enhancing the immunity of people with acquired immunodeficiency syndrome. Background technique [0002] Acquired aplastic anemia is an acquired bone marrow hematopoietic failure. The main manifestations are low bone marrow hematopoietic function, pancytopenia, anemia, bleeding, and infection syndrome, and immunosuppressive treatment is effective. According to the survey of 21 provinces (municipalities) and autonomous regions in China, the annual incidence rate is 0.74 / 100,000 population, significantly lower than the incidence rate of leukemia; the incidence rate of chronic aplastic anemia is 0.60 / 100,000 population, and the acute aplastic anemia is 0.14 / 100,000 population ; All age groups can be affected, but it is more common in young adults; the incidence rate of men is slightly higher than that o...

AI Technical Summary

Problems solved by technology

[0003] There is no traditional Chinese medicine in the prior art that can alleviate or enhance the immunity of people with acquired immunodeficiency syndrome, and the present invention is based on this